Financhill
Sell
16

CANF Quote, Financials, Valuation and Earnings

Last price:
$1.48
Seasonality move :
-5.63%
Day range:
$1.42 - $1.50
52-week range:
$1.29 - $4.69
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
13.42x
P/B ratio:
3.64x
Volume:
208.1K
Avg. volume:
815.2K
1-year change:
-28.85%
Market cap:
$9M
Revenue:
$743K
EPS (TTM):
--

Earnings Data

Next earnings date for CANF
Mar 28
2025
Most recent earnings per share
-$1.52
Missed by $1.15
(Mar 28/2024)
Consensus Estimate
-$0.37
(Mar 28/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CANF Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/28/2025 Q4 $150K -- -- -- --
12/20/2024 Q3 $150K -- -- -- --
08/29/2024 Q2 $150K -- -- -- --
06/24/2024 Q1 $150K -- -- -- --
03/28/2024 Q4 $200K $155K -$1.52 -$0.37 -$1.15
11/30/2023 Q3 -- -- -$0.43 -$0.43 -$0.00
08/25/2023 Q2 -- -- -$0.40 -$0.73 $0.32
05/26/2023 Q1 -- -- -$0.65 -$1.90 $1.25
03/24/2023 Q4 -- -- -- -$1.27 --
11/25/2022 Q3 -- -- -$1.30 -$1.05 -$0.25
08/25/2022 Q2 -- -- -$0.81 -$0.85 $0.04
05/26/2022 Q1 -- -- -$0.90 -$1.40 $0.50
03/24/2022 Q4 -- -- -$3.00 -$1.80 -$1.20
11/26/2021 Q3 -- -- -$3.00 -- --
08/26/2021 Q2 -- -- -$1.84 -- --
03/31/2021 Q1 -- -- -$1.16 -- --
03/25/2021 Q4 -- -- -- -- --
11/30/2020 Q3 -- -- -$1.67 -- --
08/27/2020 Q2 -- -- -$2.84 -- --
03/31/2020 Q1 -- -- -$9.00 -- --
12/31/2019 Q4 -- -- -$9.00 -- --
09/30/2019 Q3 -- -- -$7.39 -- --
06/30/2019 Q2 -- -- -$9.21 -- --
03/31/2019 Q1 -- -- -$12.00 -- --
12/31/2018 Q4 -- -- -$27.00 -- --
11/27/2018 Q3 -- -- -- -- --
06/30/2018 Q2 -- -- -$9.00 -- --
03/31/2018 Q1 -- -- -$15.00 -- --
12/31/2017 Q4 -- -- -$15.00 -- --
11/27/2017 Q3 -- -- -$12.00 -- --
09/01/2017 Q2 -- -- -$15.00 -- --
03/31/2017 Q1 -- -- -$15.00 -- --
12/31/2016 Q4 -- -- -$34.07 -- --
11/25/2016 Q3 -- -- -$24.81 -- --
06/30/2016 Q2 -- -- -$14.46 -- --
03/31/2016 Q1 -- -- -$16.66 -- --
12/31/2015 Q4 -- -- $8.76 -- --
09/30/2015 Q3 -- -- -$41.64 -- --
06/30/2015 Q2 -- -- -$24.82 -- --
03/31/2015 Q1 -- -- -$4.55 -- --
12/31/2014 Q4 -- -- -$26.68 -- --

Can Fite Biofarma Earnings Questions

  • How Much did Can Fite Biofarma Generate in Revenue Last Quarter?

    Can Fite Biofarma reported $155K worth of top line sales in its most recent quarter.

  • Did Can Fite Biofarma Beat Earnings Last Quarter?

    Can Fite Biofarma announced earnings per share of -$1.52 which represents a miss of analyst forecast a -$0.37 per share.

  • Is Can Fite Biofarma Profitable?

    Can Fite Biofarma reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Can Fite Biofarma EPS Next Year?

    Can Fite Biofarma's earnings are forecast to decrease from -$3.00 per share to -$1.85 per share next year representing a decrease of -51%.

  • When is Can Fite Biofarma's Earnings Date?

    Can Fite Biofarma's next earnings date is March 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock